000 01314 a2200349 4500
005 20250516114016.0
264 0 _c20130306
008 201303s 0 0 eng d
022 _a1545-7222
024 7 _a10.1176/appi.neuropsych.11070156
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aÖzdemir, Armağan
245 0 0 _aPossible paliperidone-induced neuroleptic malignant syndrome: a case report.
_h[electronic resource]
260 _bThe Journal of neuropsychiatry and clinical neurosciences
_c2012
300 _aE22-3 p.
_bdigital
500 _aPublication Type: Case Reports; Letter
650 0 4 _aAntipsychotic Agents
_xadverse effects
650 0 4 _aCreatine Kinase
_xmetabolism
650 0 4 _aHumans
650 0 4 _aIsoxazoles
_xadverse effects
650 0 4 _aMale
650 0 4 _aNeuroleptic Malignant Syndrome
_xdiagnosis
650 0 4 _aPaliperidone Palmitate
650 0 4 _aPyrimidines
_xadverse effects
650 0 4 _aSchizophrenia
_xdrug therapy
650 0 4 _aTomography, X-Ray Computed
650 0 4 _aYoung Adult
700 1 _aAksoy-Poyraz, Cana
700 1 _aKılıç-Yener, Esra
773 0 _tThe Journal of neuropsychiatry and clinical neurosciences
_gvol. 24
_gno. 3
_gp. E22-3
856 4 0 _uhttps://doi.org/10.1176/appi.neuropsych.11070156
_zAvailable from publisher's website
999 _c22159558
_d22159558